| Rank | Ticker | Exchange | Price | Market Cap | 52W High | 52W Low | Analyst Rating |
|---|---|---|---|---|---|---|---|
#1 | AAPL | Nasdaq | $338.19 | $4.5T | $342.89 | $201.50 | Buy |
#2 | V | Nasdaq | $368.73 | $613.8B | $371.16 | $293.89 | Strong Buy |
#3 | BAC | Nasdaq | $61.12 | $380.6B | $62.99 | $44.75 | Buy |
#4 | ABBV | Nasdaq | $263.58 | $358.5B | $266.92 | $187.62 | Buy |
#5 | KO | Nasdaq | $89.08 | $354.7B | $90.22 | $65.35 | Strong Buy |
#6 | RTX | Nasdaq | $215.25 | $281.7B | $221.34 | $152.66 | Buy |
#7 | SCHW | Nasdaq | $104.47 | $178.3B | $107.50 | $83.96 | Buy |
#8 | CB | Nasdaq | $361.90 | $127.9B | $365.29 | $264.10 | Buy |
#9 | BMY | Nasdaq | $63.41 | $113.5B | $64.97 | $42.52 | Buy |
#10 | MO | Nasdaq | $74.92 | $107.8B | $77.06 | $54.70 | Buy |
#11 | MNST | Nasdaq | $98.03 | $94.3B | $100.34 | $58.09 | Buy |
#12 | ABNB | Nasdaq | $153.01 | $84.8B | $152.85 | $110.81 | Buy |
#13 | CP | Nasdaq | $91.40 | $82.0B | $93.95 | $68.42 | Buy |
#14 | MDLZ | Nasdaq | $65.06 | $79.3B | $66.29 | $51.20 | Buy |
#15 | CNI | Nasdaq | $129.84 | $75.5B | $131.55 | $90.74 | Buy |
#16 | AON | Nasdaq | $377.16 | $70.4B | $382.34 | $304.59 | Buy |
#17 | ET | Nasdaq | $20.20 | $69.8B | $20.70 | $16.18 | Buy |
#18 | GM | Nasdaq | $89.40 | $68.5B | $91.15 | $51.88 | Buy |
#19 | ROST | Nasdaq | $251.96 | $68.3B | $252.09 | $134.37 | Buy |
#20 | MET | Nasdaq | $97.02 | $61.0B | $97.64 | $67.33 | Strong Buy |
#21 | TGT | Nasdaq | $145.97 | $60.1B | $145.85 | $83.44 | Buy |
#22 | ALL | Nasdaq | $274.39 | $56.9B | $271.58 | $188.08 | Buy |
#23 | CTVA | Nasdaq | $90.53 | $56.6B | $89.75 | $60.54 | Buy |
#24 | PSA | Nasdaq | $329.44 | $54.4B | $335.05 | $256.54 | Buy |
#25 | GRMN | Nasdaq | $294.83 | $49.4B | $273.32 | $186.67 | Buy |
#26 | AMP | Nasdaq | $540.29 | $46.8B | $553.46 | $422.37 | Buy |
#27 | CCEP | Nasdaq | $111.10 | $44.0B | $113.67 | $84.66 | Buy |
#28 | VIK | Nasdaq | $102.66 | $43.6B | $105.76 | $55.55 | Buy |
#29 | IQV | Nasdaq | $247.64 | $35.1B | $247.72 | $154.50 | Strong Buy |
#30 | HIG | Nasdaq | $145.68 | $34.9B | $143.98 | $120.33 | Buy |
#31 | ACGL | Nasdaq | $104.55 | $31.8B | $107.09 | $82.45 | Buy |
#32 | EXR | Nasdaq | $152.85 | $30.3B | $155.19 | $125.71 | Buy |
#33 | RPRX | Nasdaq | $59.18 | $25.9B | $60.08 | $34.63 | Strong Buy |
#34 | FCNCA | Nasdaq | $2,171.89 | $24.4B | $2,237.82 | $1,625.08 | Buy |
#35 | BURL | Nasdaq | $371.13 | $23.3B | $373.36 | $240.49 | Strong Buy |
#36 | CPAY | Nasdaq | $392.85 | $23.3B | $389.25 | $252.84 | Buy |
#37 | DGX | Nasdaq | $235.22 | $23.2B | $240.13 | $166.76 | Buy |
#38 | USFD | Nasdaq | $102.35 | $23.0B | $105.17 | $69.88 | Buy |
#39 | SN | Nasdaq | $159.22 | $21.1B | $159.46 | $83.12 | Strong Buy |
#40 | LH | Nasdaq | $307.15 | $21.0B | $315.23 | $244.52 | Buy |
#41 | ROKU | Nasdaq | $145.33 | $20.9B | $148.88 | $78.53 | Strong Buy |
#42 | SNA | Nasdaq | $414.83 | $19.1B | $420.67 | $312.78 | Buy |
#43 | VTRS | Nasdaq | $17.82 | $18.7B | $17.94 | $8.63 | Buy |
#44 | THC | Nasdaq | $257.62 | $17.8B | $261.58 | $156.72 | Buy |
#45 | KIM | Nasdaq | $26.02 | $17.6B | $26.65 | $19.76 | Buy |
#46 | PAA | Nasdaq | $24.89 | $17.4B | $24.87 | $15.69 | Buy |
#47 | PFGC | Nasdaq | $117.15 | $17.3B | $116.71 | $80.82 | Strong Buy |
#48 | BIP | Nasdaq | $42.62 | $16.8B | $42.00 | $29.63 | Buy |
#49 | BBY | Nasdaq | $90.17 | $16.4B | $90.72 | $55.10 | Buy |
#50 | CLH | Nasdaq | $326.34 | $16.1B | $316.98 | $201.34 | Buy |
The FinQuota filters have identified what they believe to be the "NASDAQ 52 Week High Stocks (July 29, 2026) | FinQuota" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.